--- product_id: 401812143 title: "The Pharmagellan Guide to Analyzing Biotech Clinical Trials" price: "463 zł" currency: PLN in_stock: true reviews_count: 5 url: https://www.desertcart.pl/products/401812143-the-pharmagellan-guide-to-analyzing-biotech-clinical-trials store_origin: PL region: Poland --- # The Pharmagellan Guide to Analyzing Biotech Clinical Trials **Price:** 463 zł **Availability:** ✅ In Stock ## Quick Answers - **What is this?** The Pharmagellan Guide to Analyzing Biotech Clinical Trials - **How much does it cost?** 463 zł with free shipping - **Is it available?** Yes, in stock and ready to ship - **Where can I buy it?** [www.desertcart.pl](https://www.desertcart.pl/products/401812143-the-pharmagellan-guide-to-analyzing-biotech-clinical-trials) ## Best For - Customers looking for quality international products ## Why This Product - Free international shipping included - Worldwide delivery with tracking - 15-day hassle-free returns ## Description The Pharmagellan Guide to Analyzing Biotech Clinical Trials : David, Frank S.: desertcart.co.uk: Books Review: best general book about clinical trials for strategists (regulatory, clinical, finance, etc) - It is very useful in due dilligence or any other multi-functional appraisal project of clinical trials, but is also a fantastic and up to date book for both advanced beginners and experts looking for a reference or good reading/recall of all main aspects of clinical trials. The author states that he has reviewed hundreds of books and articles about trials but hasn't found one as integrated like this one. I agree. I have also read hundreds of such books/articles on trials and they are usually either too operational (how to file an IND, Clinical trial application, monitor a clinical site, etc) or too narrow for one function/expert in one area (e.g. statistical analysis or any particular therapeutic area details). This book is unique in that indeed is a great resource for all therapeutic areas and functions. It provides an integrated perspective useful for strategists of new clinical trials programs of all functions from regulatory to commercial, from clinical to finance. Every major issue that can come up in a multi functional analysis of a trial is stated and explained. For example even the practice of endpoint switching at the last minute by biotech start ups or others eager to demonstrate results when they only have one shot (only funds for one clinical trial) at goal is covered with recent and relevant examples. Great job. Thank you so much to the author Frank David for a resource full of great and recent examples, extensive reference list of many aspects of clinical trials and how to handle them. Importantly, although is general for every particular issue the author is well-read in all aspects of clinical trials and refers you to more detailed texts about each topic that you may need to explore further in the particular clinical trial you are organizing or analyzing. Review: Honestly, it’s a great book. If you’re in biotech and you need a simplified overview of the intricacies of drug clinical trials and how they’re presented this is for you. It’s pretty unique in explaining statistical formulas and derivations of trial reporting as well as presenting the complexities of the the whole process. Waited a while to buy, but I’m glad I did. Worth the money if you read it cover to cover. ## Technical Specifications | Specification | Value | |---------------|-------| | Best Sellers Rank | 464,213 in Books ( See Top 100 in Books ) 163 in Bioengineering 352 in Medical Research & Equipment 3,862 in General Medical Issues Guides | | Customer reviews | 4.2 4.2 out of 5 stars (38) | | Dimensions | 15.24 x 1.85 x 22.86 cm | | ISBN-10 | 0998407526 | | ISBN-13 | 978-0998407524 | | Item weight | 1.05 kg | | Language | English | | Print length | 292 pages | | Publication date | 21 Jan. 2022 | | Publisher | Pharmagellan | ## Images ![The Pharmagellan Guide to Analyzing Biotech Clinical Trials - Image 1](https://m.media-amazon.com/images/I/61b+h8AXIwL.jpg) ![The Pharmagellan Guide to Analyzing Biotech Clinical Trials - Image 2](https://m.media-amazon.com/images/I/719kM54JHhL.jpg) ## Customer Reviews ### ⭐⭐⭐⭐⭐ best general book about clinical trials for strategists (regulatory, clinical, finance, etc) *by P***O on 9 May 2022* It is very useful in due dilligence or any other multi-functional appraisal project of clinical trials, but is also a fantastic and up to date book for both advanced beginners and experts looking for a reference or good reading/recall of all main aspects of clinical trials. The author states that he has reviewed hundreds of books and articles about trials but hasn't found one as integrated like this one. I agree. I have also read hundreds of such books/articles on trials and they are usually either too operational (how to file an IND, Clinical trial application, monitor a clinical site, etc) or too narrow for one function/expert in one area (e.g. statistical analysis or any particular therapeutic area details). This book is unique in that indeed is a great resource for all therapeutic areas and functions. It provides an integrated perspective useful for strategists of new clinical trials programs of all functions from regulatory to commercial, from clinical to finance. Every major issue that can come up in a multi functional analysis of a trial is stated and explained. For example even the practice of endpoint switching at the last minute by biotech start ups or others eager to demonstrate results when they only have one shot (only funds for one clinical trial) at goal is covered with recent and relevant examples. Great job. Thank you so much to the author Frank David for a resource full of great and recent examples, extensive reference list of many aspects of clinical trials and how to handle them. Importantly, although is general for every particular issue the author is well-read in all aspects of clinical trials and refers you to more detailed texts about each topic that you may need to explore further in the particular clinical trial you are organizing or analyzing. ### ⭐⭐⭐⭐⭐ Review *by G***Y on 11 June 2022* Honestly, it’s a great book. If you’re in biotech and you need a simplified overview of the intricacies of drug clinical trials and how they’re presented this is for you. It’s pretty unique in explaining statistical formulas and derivations of trial reporting as well as presenting the complexities of the the whole process. Waited a while to buy, but I’m glad I did. Worth the money if you read it cover to cover. ### ⭐⭐⭐⭐⭐ Review *by R***A on 8 March 2022* Book ID thorough comprehensive clearly written and easy to follow. Highly recommend it. --- ## Why Shop on Desertcart? - 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016 - 🌍 **Shop Globally** — Access 737+ million products across 21 categories - 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price - 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members) - 🔒 **Secure Payments** — Trusted payment options with buyer protection - ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews **Shop now:** [https://www.desertcart.pl/products/401812143-the-pharmagellan-guide-to-analyzing-biotech-clinical-trials](https://www.desertcart.pl/products/401812143-the-pharmagellan-guide-to-analyzing-biotech-clinical-trials) --- *Product available on Desertcart Poland* *Store origin: PL* *Last updated: 2026-05-15*